Lophophine (original) (raw)

From Wikipedia, the free encyclopedia

Chemical compound

Pharmaceutical compound

Lophophine

Clinical data
Other names 3-Methoxy-4,5-methylenedioxyphenethylamine; MMDPEA
Routes of administration Oral
ATC code none
Legal status
Legal status Uncontrolled (but may be covered under the Federal Analogue Act in the United States and under similar bills in other countries due to its similarity to mescaline and MMDA)
Identifiers
IUPAC name 2-(7-methoxy-1,3-benzodioxol-5-yl)ethanamine
CAS Number 23693-38-1 checkY
PubChem CID 90239
ChemSpider 81465 checkY
UNII C68IB79RC2
ChEMBL ChEMBL159620 checkY
CompTox Dashboard (EPA) DTXSID80178357 Edit this at Wikidata
ECHA InfoCard 100.041.645 Edit this at Wikidata
Chemical and physical data
Formula C10H13NO3
Molar mass 195.218 g·mol−1
3D model (JSmol) Interactive image
SMILES O1c2cc(cc(OC)c2OC1)CCN
InChI InChI=1S/C10H13NO3/c1-12-8-4-7(2-3-11)5-9-10(8)14-6-13-9/h4-5H,2-3,6,11H2,1H3 checkYKey:ORXQUAPZHKCCAX-UHFFFAOYSA-N checkY
(verify)

Lophophine, also known as 3-methoxy-4,5-methylenedioxyphenethylamine (MMDPEA), is a putative psychedelic and entactogen drug of the methylenedioxyphenethylamine family. It is the α-demethylated homologue of MMDA, and is also closely related to mescaline.

Alexander Shulgin originally suggested that lophophine may be a natural constituent of peyote (Lophophora williamsii) due to it being the only logical chemical intermediate for the biosynthesis of several tetrahydroisoquinolines known to be present in this cactus species.[1] Subsequently, lophophine was indeed shown to be a minor component of both peyote and San Pedro cactus.[2]

Shulgin reports that lophophine is active in the dosage range of 150–250 mg. He states that at these doses, lophophine has some similarity to mescaline in action, in producing a peaceful elevation of mood, euphoria, and mild enhancement of visual perception, but without the generation of closed-eye mental imagery. Shulgin also notes that (in contrast to mescaline), lophophine causes no nausea.[1]

  1. ^ a b A. Shulgin and A. Shulgin (1991). Pihkal. Berkeley: Transform Press. pp. 701–702.
  2. ^ Bruhn JG, El-Seedi HR, Stephanson N, Beck O, Shulgin AT (June 2008). "Ecstasy analogues found in cacti". Journal of Psychoactive Drugs. 40 (2): 219–22. CiteSeerX 10.1.1.689.4014. doi:10.1080/02791072.2008.10400635. PMID 18720674. S2CID 11251286.

Categories: